Literature DB >> 4000433

Microvascular decompression in hemifacial spasm: intraoperative electrophysiological observations.

A R Møller, P J Jannetta.   

Abstract

Facial muscle responses in patients with hemifacial spasm undergoing microvascular decompression operations were recorded. Two peripheral branches of the facial nerve were stimulated and the electrical responses of muscles innervated by these branches were studied to see how the lateral spread of activity that is known to be present in these patients was affected by decompressing the facial nerve. In some of the patients the hemifacial spasm ceased when the dura mater was opened, in some it ceased when the arachnoid was opened, and in others the spasm persisted until the offending vessel was dissected away from the nerve. The lateral spread of activity elicited by antidromic stimulation of a branch of the facial nerve was less affected by opening of the dura mater or arachnoid: it usually persisted until the blood vessel that had been compressing the facial nerve was removed and reappeared when the vessel that had been compressing the facial nerve was allowed to slip back onto the nerve. This seems to indicate that microvascular decompression of the facial nerve is effective in alleviating hemifacial spasm because it removes the actual cause of the disorder rather than simply causing local injury to the nerve as a result of the procedure.

Entities:  

Mesh:

Year:  1985        PMID: 4000433     DOI: 10.1227/00006123-198505000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  27 in total

1.  Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1,174 operations.

Authors:  Seung-Jae Hyun; Doo-Sik Kong; Kwan Park
Journal:  Neurosurg Rev       Date:  2010-03-27       Impact factor: 3.042

Review 2.  The cranial nerve vascular compression syndrome: I. A review of treatment.

Authors:  A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Hemifacial spasm: a neurosurgical perspective.

Authors:  Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

4.  Microvascular decompression for hemifacial spasm: focus on late reoperation.

Authors:  Xuhui Wang; Parthasarathy D Thirumala; Aalap Shah; Paul Gardner; Miguel Habeych; Donald Crammond; Jeffrey Balzer; Lois Burkhart; Michael Horowitz
Journal:  Neurosurg Rev       Date:  2013-06-10       Impact factor: 3.042

5.  Intra-operative monitoring by facial electromyographic responses during microvascular decompressive surgery for hemifacial spasm.

Authors:  T Isu; K Kamada; S Mabuchi; A Kitaoka; T Ito; M Koiwa; H Abe
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Residual hemifacial spasm after microvascular decompression: prognostic factors with emphasis on preoperative psychological state.

Authors:  Yichao Jin; Changyi Zhao; Shanshan Su; Xiaohua Zhang; Yongming Qiu; Jiyao Jiang
Journal:  Neurosurg Rev       Date:  2015-04-15       Impact factor: 3.042

7.  The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients.

Authors:  Ahmed El Damaty; Christian Rosenstengel; Marc Matthes; Joerg Baldauf; Henry W S Schroeder
Journal:  Neurosurg Rev       Date:  2016-04-06       Impact factor: 3.042

8.  Microvascular decompression for familial hemifacial spasm : single institute experience.

Authors:  Jae-Han Park; Kyung-Il Jo; Hyun-Seok Lee; Jung-A Lee; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2013-01-31

9.  Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats.

Authors:  A Kuroki; A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 10.  The cranial nerve vascular compression syndrome: II. A review of pathophysiology.

Authors:  A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.